Pediatric Drugs

Acknowledgement
pp. 783-785(3)
Author: Adis International Limited

Long-Term Use of Stimulants in Children with Attention Deficit Hyperactivity Disorder: Safety, Efficacy, and Long-Term Outcome
pp. 787-794(8)
Authors: Hechtman L.; Greenfield B.

Refractory Idiopathic Immune Thrombocytopenic Purpura in Children: Current and Future Treatment Options
pp. 795-801(7)
Author: Imbach P.

Anticoagulation Therapy in Children
pp. 803-820(18)
Authors: Ronghe M.D.; Halsey C.; Goulden N.J.

Community-Acquired Pneumonia in Children: Issues in Optimizing Antibacterial Treatment
pp. 821-832(12)
Author: Korppi M.

Efficacy and Safety of Ritalin^® LA™, a New, Once Daily, Extended-Release Dosage Form of Methylphenidate, in Children with Attention Deficit Hyperactivity Disorder
pp. 833-841(9)
Authors: Biederman J.; Quinn D.; Weiss M.; Markabi S.; Weidenman M.; Edson K.; Karlsson G.; Pohlmann H.; Wigal S.